Comparing Combigan vs Cosopt PF
| Combigan (brimonidine / timolol) | Cosopt PF (dorzolamide / timolol) |
|
|---|
| Combigan (brimonidine / timolol) | Cosopt PF (dorzolamide / timolol) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Glaucoma, Glaucoma/Intraocular Hypertension, Intraocular Hypertension. Combigan may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Glaucoma - Open Angle, Intraocular Hypertension. Cosopt PF may also be used for purposes not listed in this medication guide. |
Related suggestions Intraocular Hypertension
|
|||||||
| More about Combigan (brimonidine / timolol) | More about Cosopt PF (dorzolamide / timolol) | ||||||||
| Ratings & Reviews | |||||||||
|
Combigan has an average rating of 4.9 out of 10 from a total of 25 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 48% reported a negative effect. |
Cosopt PF has an average rating of 4.7 out of 10 from a total of 3 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 33% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Combigan side effects |
View all Cosopt PF side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Combigan prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
|
||||||||
| Brand Names | |||||||||
|
N/A |
Other dorzolamide / timolol brands include: Cosopt | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
7 hours |
N/A |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 548 drugs are known to interact with Combigan:
|
A total of 291 drugs are known to interact with Cosopt PF:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
October 30, 2007 |
N/A |
||||||||
| WADA Class View classifications | |||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Diamox
Diamox is used for edema, epilepsy, glaucoma, hydrocephalus, mountain sickness / altitude sickness ...
Xalatan
Xalatan (latanoprost) is used to treat certain types of glaucoma. Includes Xalatan side effects ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Lumigan
Lumigan is used to treat open angle glaucoma. Learn about side effects, interactions and indications.
Cosopt
Cosopt reduces the amount of fluid in the eye and is used to treat glaucoma. Learn about side ...
Alphagan P
Alphagan P is used to treat glaucoma or ocular hypertension (high pressure inside the eye). Learn ...
Vyzulta
Vyzulta is used for glaucoma, open angle, glaucoma/intraocular hypertension
Rhopressa
Rhopressa is used for glaucoma, open angle, intraocular hypertension
Simbrinza
Simbrinza (brimonidine and brinzolamide) is used to treat open-angle glaucoma or ocular ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.